Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Nasrallah, Rania ^a   Landry, Anne ^a   Singh, Sonia ^a   Sklepowicz, Monika ^a   Hébert, Richard L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

EP4 receptor; Inner medullary collecting duct; Prostaglandin E2; Streptozotocin diabetic rats

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN SYNTHASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; KIDNEY COLLECTING TUBULE; KIDNEY FUNCTION; KIDNEY MEDULLA; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; WESTERN BLOTTING;

EID: 0242665713     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00434.2002     Document Type: Article

References (49)

1. 2 receptors. Proc Natl Acad Sci USA 95: 15792-15797, 1998.
2. 4 in the nuclear envelope. J Biol Chem 274: 15719-15724, 1999.
3. Bonvalet JP, Pradelles P, and Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 253: F377-F387, 1987.
4. Breyer M, Davis L, Jacobson H, and Breyer R. Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol Renal Fluid Electrolyte Physiol 270: F912-F918, 1996.
5. Breyer MD, Zhang YH, Guan YF, Hao CM, Hébert RL, and Breyer RM. Regulation of renal function by prostaglandin E receptors. Kidney Int 67: 588-594, 1998.
6. Buschhausen L, Seibold S, Gross O, Matthaeus T, Weber M, and Schulze-Lohoff E. Regulation of mesangial cell function by vasodilatory signaling molecules. Cardiovasc Res 51: 463-469, 2001.
7. Cheng HF, Wang JL, Zhang MZ, McKanna JA, and Harris RC. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest 106: 681-688, 2000.
8. Coleman RA, Smith WL, and Naruming S. VIII International union of pharmacology classification of prostanoid receptors: properties distribution and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
9. DeRubertis FR and Craven PA. Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am J Kidney Dis 22: 727-35, 1993.
10. DeWitt DL. Cox-2 selective inhibitors: the new super aspirins. Mol Pharmacol 55: 625-631, 1999.
11. Ferguson S, Hebert RL, and Laneuville O. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. J Am Soc Nephrol 10: 2261-2271, 1999.
12. 2. Am J Physiol Renal Physiol 275: F955-F961, 1998.
13. 1α and TXB2 in newly diagnosed type I diabetic patients. Diabetes 37: 1044-1048, 1988.
14. Guan Y, Chang M, Cho W, Zhang Y, Redha R, Davis L, Chang S, DuBois RN, Hao CM, and Breyer M. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol Renal Physiol 273: F18-F26, 1997.
15. Hao CM, Yull F, Blackwell T, Komhoff M, Davis LS, and Breyer MD. Dehydration activates an NF-κB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J Clin Invest 106: 973-982, 2000.
16. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, and Breyer MD. Cyclooxygenase-1 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 97: 2051-2056, 1994.
17. Hatae T, Wada M, Yokoyama C, Shimonishi M, and Tanabe T. Prostacyclin-dependent apoptosis mediated by PPARδ. J Biol Chem 276: 46260-46267, 2001.
18. Hébert RL, O'Connor T, Neville C, Burns KD, Laneuville O, and Peterson LN. Prostanoid signalling, localization and expression of IP receptors in rat thick ascending limb cells. Am J Physiol Renal Physiol 275: F904-F914, 1998.
19. Homma T, Ichikawa I, and Hoover RL. Prostaglandins of mesangium origin inhibit mesangial cell proliferation and matrix synthesis (Abstract). Kidney Int 33: 268, 1988.
20. Ishibashi R, Tanaka I, Kotani M, Muro S, Goto M, Sugawara A, Mukoyama M, Sugimoto Y, Ichikawa A, Narumiya S, and Nakao K. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. Kidney Int 56: 589-600, 1999.
21. Kang MJ, Wu X, HLY, Thai K, and Scholey JW. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney Int 55: 2203-2214, 1999.
22. Koh E, Morimoto S, Jiang B, Inoue T, Nabata T, Kitano S, Yasuda O, Fukuo K, and Ogihara T. Effects of beraprost sodium, a stable analogue of prostacyclin, on hyperplasia, hypertrophy and glycosaminoglycan synthesis of rat aortic smooth muscle cells. Artery 20: 242-252, 1999.
23. Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, and Anderson S. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 107: 889-898, 2001.
24. Komhoff M, Grone HJ, Klein T, Seyberth HW, and Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol Renal Physiol 272: F460-F468, 1997.
25. Kreisberg JI and Patel PY. The effects of insulin, glucose, and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukot Med 11: 431-442, 1983.
26. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, and Smithies C. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492, 1995.
27. Lee HB, Ha H, Kim SI, and Ziyadeh FN. Diabetic kidney disease research: where do we stand at the turn of the century? Kidney Int 58, Suppl 77: S1-S2, 2000.
28. 1-selective antagonist. J Am Soc Nephrol 13: 1757-1765, 2002.
29. 4 in human kidney. J Am Soc Nephrol 10: 1851-1860, 1999.
30. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, and Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995.
31. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties and functions. Physiol Rev 79: 1193-1226, 1999.
32. 2 receptor subtypes in M-1 mouse CCD cells. Am J Physiol Renal Physiol 281: F123-F132, 2001.
33. Nasrallah R, Zimplemann J, Singh S, and Hébert RL. Molecular and biochemical characterization of prostacyclin (IP) receptors in the rat kidney. Am J Physiol Renal Physiol 280: F266-F277, 2001.
34. 2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells. Biochem J 313: 617-623, 1996.
35. Paller MS and Manivel JC. Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 42: 1345-1354, 1992.
36. Porte M and Schwartz W. Diabetes complications: why is glucose potentially toxic? Science 272: 699-700, 1996.
37. Rossat J, Maillard M, Nussberger J, Brunner HR, and Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 66: 76-84, 1999.
38. Sanchez PL, Salgado LM, Ferreri NR, and Escalante B. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. Hypertension 34: 848-853, 1999.
39. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, and Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75: 404-412, 1985.
40. Scharschmidt LA and Dunn MJ. Prostaglandin synthesis by rat glomerular mesangial cells in culture: effects of angiotensin II and arginine vasopressin. J Clin Invest 71: 1756-1764, 1983.
41. Schlein PS, O'Connell MJ, Blom J, Hubbard S, Magrath IT, Bergevin P, Wiernik PH, Ziegler JL, and DeVita VT. Clinical antitumor activity and toxicity of streptozotocin. Cancer 34: 993-1000, 1974.
42. Schramek H, Sorokin A, Watson RD, and Dunn MJ. ET-1 and PDGF BB induce MEK mRNA and protein expression in mesangial cells. J Cardiovasc Pharmacol 26, Suppl 3: S95-S99, 1995.
43. Smith WL and Bell TG. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol Renal Fluid Electrolyte Physiol 235: F451-F457, 1978.
44. Smith WL and DeWitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62: 167-215, 1996.
45. Sonnenburg WK, Zhu J, and Smith WL. A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J Biol Chem 265: 8479-8483, 1990.
46. Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, and Narumiya S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol Renal Fluid Electrolyte Physiol 266: F823-F828, 1994.
47. Viberti GC, Benigni A, Bognetti E, Remuzzi G, and Wiseman MJ. Glomerular hyperfiltration and urinary prostaglandins in type I diabetes mellitus. Diabetic Med 6: 219-223, 1989.
48. Villa E, Rabano A, Ruilope LM, and Garcia-Robles R. Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. Am J Hypertens 10: 202-208, 1997.
49. Watanabe K, Kurihara K, Tokunaga Y, and Hayaishi O. Two types of microsomal prostaglandin E synthase: glutathione-dependent and independent prostaglandin E synthases. Biochem Biophys Res Commun 235: 148-152, 1997.